Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2025-2031

Product Code: 1606247

Industry: Service & Software

Published: May 27,2025

Pages: 132

Delivery Time: 2-3 business days

Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2025-2031

Product Code: 1606247

Industry: Service & Software

Published: May 27,2025

Pages: 132

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global Artificial Intelligence Drug R&D market size will reach US$ 1250 million by 2031.

Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Artificial Intelligence Drug R&D Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Drug R&D sales in 2024, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug R&D sales for 2025 through 2031. With Artificial Intelligence Drug R&D sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug R&D industry.

This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug R&D landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Drug R&D portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Drug R&D market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug R&D and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug R&D.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug R&D market by product type, application, key players and key regions and countries.

Segmentation by Type:
    AI Platfrom
    Analytics Service

Segmentation by Application:
    Drug Discovery
    Precision Medicine

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    IBM Watson
    BioXel
    Insilico Medicine
    Gatehouse Bio
    Google DeepMind
    Genpact Cora
    Cyclica Inc
    QuantumBlack
    Nq Medical
    Phenomic AI
    Palantir Technologies
    BenevolentAI
    Atomwise
    Numerate
    Recursion Pharmaceuticals
    Exscientia
    TwoXAR
    AiCure

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Artificial Intelligence Drug R&D Market Size (2020-2031)
        2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Artificial Intelligence Drug R&D by Country/Region (2020, 2024 & 2031)
    2.2 Artificial Intelligence Drug R&D Segment by Type
        2.2.1 AI Platfrom
        2.2.2 Analytics Service
    2.3 Artificial Intelligence Drug R&D Market Size by Type
        2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2020-2025)
    2.4 Artificial Intelligence Drug R&D Segment by Application
        2.4.1 Drug Discovery
        2.4.2 Precision Medicine
    2.5 Artificial Intelligence Drug R&D Market Size by Application
        2.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2020-2025)

3 Artificial Intelligence Drug R&D Market Size by Player
    3.1 Artificial Intelligence Drug R&D Market Size Market Share by Player
        3.1.1 Global Artificial Intelligence Drug R&D Revenue by Player (2020-2025)
        3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2020-2025)
    3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Artificial Intelligence Drug R&D by Region
    4.1 Artificial Intelligence Drug R&D Market Size by Region (2020-2025)
    4.2 Global Artificial Intelligence Drug R&D Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Artificial Intelligence Drug R&D Market Size Growth (2020-2025)
    4.4 APAC Artificial Intelligence Drug R&D Market Size Growth (2020-2025)
    4.5 Europe Artificial Intelligence Drug R&D Market Size Growth (2020-2025)
    4.6 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2020-2025)
    5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2020-2025)
    5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2020-2025)
    6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2020-2025)
    6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Artificial Intelligence Drug R&D Market Size by Country (2020-2025)
    7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2020-2025)
    7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2020-2025)
    8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2020-2025)
    8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Artificial Intelligence Drug R&D Market Forecast
    10.1 Global Artificial Intelligence Drug R&D Forecast by Region (2026-2031)
        10.1.1 Global Artificial Intelligence Drug R&D Forecast by Region (2026-2031)
        10.1.2 Americas Artificial Intelligence Drug R&D Forecast
        10.1.3 APAC Artificial Intelligence Drug R&D Forecast
        10.1.4 Europe Artificial Intelligence Drug R&D Forecast
        10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
    10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2026-2031)
        10.2.1 United States Market Artificial Intelligence Drug R&D Forecast
        10.2.2 Canada Market Artificial Intelligence Drug R&D Forecast
        10.2.3 Mexico Market Artificial Intelligence Drug R&D Forecast
        10.2.4 Brazil Market Artificial Intelligence Drug R&D Forecast
    10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2026-2031)
        10.3.1 China Artificial Intelligence Drug R&D Market Forecast
        10.3.2 Japan Market Artificial Intelligence Drug R&D Forecast
        10.3.3 Korea Market Artificial Intelligence Drug R&D Forecast
        10.3.4 Southeast Asia Market Artificial Intelligence Drug R&D Forecast
        10.3.5 India Market Artificial Intelligence Drug R&D Forecast
        10.3.6 Australia Market Artificial Intelligence Drug R&D Forecast
    10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2026-2031)
        10.4.1 Germany Market Artificial Intelligence Drug R&D Forecast
        10.4.2 France Market Artificial Intelligence Drug R&D Forecast
        10.4.3 UK Market Artificial Intelligence Drug R&D Forecast
        10.4.4 Italy Market Artificial Intelligence Drug R&D Forecast
        10.4.5 Russia Market Artificial Intelligence Drug R&D Forecast
    10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2026-2031)
        10.5.1 Egypt Market Artificial Intelligence Drug R&D Forecast
        10.5.2 South Africa Market Artificial Intelligence Drug R&D Forecast
        10.5.3 Israel Market Artificial Intelligence Drug R&D Forecast
        10.5.4 Turkey Market Artificial Intelligence Drug R&D Forecast
    10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2026-2031)
    10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Artificial Intelligence Drug R&D Forecast

11 Key Players Analysis
    11.1 IBM Watson
        11.1.1 IBM Watson Company Information
        11.1.2 IBM Watson Artificial Intelligence Drug R&D Product Offered
        11.1.3 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 IBM Watson Main Business Overview
        11.1.5 IBM Watson Latest Developments
    11.2 BioXel
        11.2.1 BioXel Company Information
        11.2.2 BioXel Artificial Intelligence Drug R&D Product Offered
        11.2.3 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 BioXel Main Business Overview
        11.2.5 BioXel Latest Developments
    11.3 Insilico Medicine
        11.3.1 Insilico Medicine Company Information
        11.3.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
        11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 Insilico Medicine Main Business Overview
        11.3.5 Insilico Medicine Latest Developments
    11.4 Gatehouse Bio
        11.4.1 Gatehouse Bio Company Information
        11.4.2 Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
        11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Gatehouse Bio Main Business Overview
        11.4.5 Gatehouse Bio Latest Developments
    11.5 Google DeepMind
        11.5.1 Google DeepMind Company Information
        11.5.2 Google DeepMind Artificial Intelligence Drug R&D Product Offered
        11.5.3 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Google DeepMind Main Business Overview
        11.5.5 Google DeepMind Latest Developments
    11.6 Genpact Cora
        11.6.1 Genpact Cora Company Information
        11.6.2 Genpact Cora Artificial Intelligence Drug R&D Product Offered
        11.6.3 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Genpact Cora Main Business Overview
        11.6.5 Genpact Cora Latest Developments
    11.7 Cyclica Inc
        11.7.1 Cyclica Inc Company Information
        11.7.2 Cyclica Inc Artificial Intelligence Drug R&D Product Offered
        11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 Cyclica Inc Main Business Overview
        11.7.5 Cyclica Inc Latest Developments
    11.8 QuantumBlack
        11.8.1 QuantumBlack Company Information
        11.8.2 QuantumBlack Artificial Intelligence Drug R&D Product Offered
        11.8.3 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 QuantumBlack Main Business Overview
        11.8.5 QuantumBlack Latest Developments
    11.9 Nq Medical
        11.9.1 Nq Medical Company Information
        11.9.2 Nq Medical Artificial Intelligence Drug R&D Product Offered
        11.9.3 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Nq Medical Main Business Overview
        11.9.5 Nq Medical Latest Developments
    11.10 Phenomic AI
        11.10.1 Phenomic AI Company Information
        11.10.2 Phenomic AI Artificial Intelligence Drug R&D Product Offered
        11.10.3 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Phenomic AI Main Business Overview
        11.10.5 Phenomic AI Latest Developments
    11.11 Palantir Technologies
        11.11.1 Palantir Technologies Company Information
        11.11.2 Palantir Technologies Artificial Intelligence Drug R&D Product Offered
        11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Palantir Technologies Main Business Overview
        11.11.5 Palantir Technologies Latest Developments
    11.12 BenevolentAI
        11.12.1 BenevolentAI Company Information
        11.12.2 BenevolentAI Artificial Intelligence Drug R&D Product Offered
        11.12.3 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 BenevolentAI Main Business Overview
        11.12.5 BenevolentAI Latest Developments
    11.13 Atomwise
        11.13.1 Atomwise Company Information
        11.13.2 Atomwise Artificial Intelligence Drug R&D Product Offered
        11.13.3 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 Atomwise Main Business Overview
        11.13.5 Atomwise Latest Developments
    11.14 Numerate
        11.14.1 Numerate Company Information
        11.14.2 Numerate Artificial Intelligence Drug R&D Product Offered
        11.14.3 Numerate Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 Numerate Main Business Overview
        11.14.5 Numerate Latest Developments
    11.15 Recursion Pharmaceuticals
        11.15.1 Recursion Pharmaceuticals Company Information
        11.15.2 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
        11.15.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.15.4 Recursion Pharmaceuticals Main Business Overview
        11.15.5 Recursion Pharmaceuticals Latest Developments
    11.16 Exscientia
        11.16.1 Exscientia Company Information
        11.16.2 Exscientia Artificial Intelligence Drug R&D Product Offered
        11.16.3 Exscientia Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.16.4 Exscientia Main Business Overview
        11.16.5 Exscientia Latest Developments
    11.17 TwoXAR
        11.17.1 TwoXAR Company Information
        11.17.2 TwoXAR Artificial Intelligence Drug R&D Product Offered
        11.17.3 TwoXAR Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.17.4 TwoXAR Main Business Overview
        11.17.5 TwoXAR Latest Developments
    11.18 AiCure
        11.18.1 AiCure Company Information
        11.18.2 AiCure Artificial Intelligence Drug R&D Product Offered
        11.18.3 AiCure Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2020-2025)
        11.18.4 AiCure Main Business Overview
        11.18.5 AiCure Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Artificial Intelligence Drug R&D Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of AI Platfrom
 Table 4. Major Players of Analytics Service
 Table 5. Artificial Intelligence Drug R&D Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 6. Global Artificial Intelligence Drug R&D Market Size by Type (2020-2025) & ($ millions)
 Table 7. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2020-2025)
 Table 8. Artificial Intelligence Drug R&D Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 9. Global Artificial Intelligence Drug R&D Market Size by Application (2020-2025) & ($ millions)
 Table 10. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2020-2025)
 Table 11. Global Artificial Intelligence Drug R&D Revenue by Player (2020-2025) & ($ millions)
 Table 12. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2020-2025)
 Table 13. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
 Table 14. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global Artificial Intelligence Drug R&D Market Size by Region (2020-2025) & ($ millions)
 Table 18. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2020-2025)
 Table 19. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2020-2025) & ($ millions)
 Table 20. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2020-2025)
 Table 21. Americas Artificial Intelligence Drug R&D Market Size by Country (2020-2025) & ($ millions)
 Table 22. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2020-2025)
 Table 23. Americas Artificial Intelligence Drug R&D Market Size by Type (2020-2025) & ($ millions)
 Table 24. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2020-2025)
 Table 25. Americas Artificial Intelligence Drug R&D Market Size by Application (2020-2025) & ($ millions)
 Table 26. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2020-2025)
 Table 27. APAC Artificial Intelligence Drug R&D Market Size by Region (2020-2025) & ($ millions)
 Table 28. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2020-2025)
 Table 29. APAC Artificial Intelligence Drug R&D Market Size by Type (2020-2025) & ($ millions)
 Table 30. APAC Artificial Intelligence Drug R&D Market Size by Application (2020-2025) & ($ millions)
 Table 31. Europe Artificial Intelligence Drug R&D Market Size by Country (2020-2025) & ($ millions)
 Table 32. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2020-2025)
 Table 33. Europe Artificial Intelligence Drug R&D Market Size by Type (2020-2025) & ($ millions)
 Table 34. Europe Artificial Intelligence Drug R&D Market Size by Application (2020-2025) & ($ millions)
 Table 35. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2020-2025) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
 Table 39. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
 Table 40. Key Industry Trends of Artificial Intelligence Drug R&D
 Table 41. Global Artificial Intelligence Drug R&D Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 42. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Region (2026-2031)
 Table 43. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 44. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 45. IBM Watson Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 46. IBM Watson Artificial Intelligence Drug R&D Product Offered
 Table 47. IBM Watson Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 48. IBM Watson Main Business
 Table 49. IBM Watson Latest Developments
 Table 50. BioXel Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 51. BioXel Artificial Intelligence Drug R&D Product Offered
 Table 52. BioXel Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 53. BioXel Main Business
 Table 54. BioXel Latest Developments
 Table 55. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 56. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
 Table 57. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 58. Insilico Medicine Main Business
 Table 59. Insilico Medicine Latest Developments
 Table 60. Gatehouse Bio Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 61. Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
 Table 62. Gatehouse Bio Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 63. Gatehouse Bio Main Business
 Table 64. Gatehouse Bio Latest Developments
 Table 65. Google DeepMind Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 66. Google DeepMind Artificial Intelligence Drug R&D Product Offered
 Table 67. Google DeepMind Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 68. Google DeepMind Main Business
 Table 69. Google DeepMind Latest Developments
 Table 70. Genpact Cora Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 71. Genpact Cora Artificial Intelligence Drug R&D Product Offered
 Table 72. Genpact Cora Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 73. Genpact Cora Main Business
 Table 74. Genpact Cora Latest Developments
 Table 75. Cyclica Inc Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 76. Cyclica Inc Artificial Intelligence Drug R&D Product Offered
 Table 77. Cyclica Inc Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 78. Cyclica Inc Main Business
 Table 79. Cyclica Inc Latest Developments
 Table 80. QuantumBlack Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 81. QuantumBlack Artificial Intelligence Drug R&D Product Offered
 Table 82. QuantumBlack Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 83. QuantumBlack Main Business
 Table 84. QuantumBlack Latest Developments
 Table 85. Nq Medical Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 86. Nq Medical Artificial Intelligence Drug R&D Product Offered
 Table 87. Nq Medical Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 88. Nq Medical Main Business
 Table 89. Nq Medical Latest Developments
 Table 90. Phenomic AI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 91. Phenomic AI Artificial Intelligence Drug R&D Product Offered
 Table 92. Phenomic AI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 93. Phenomic AI Main Business
 Table 94. Phenomic AI Latest Developments
 Table 95. Palantir Technologies Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 96. Palantir Technologies Artificial Intelligence Drug R&D Product Offered
 Table 97. Palantir Technologies Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 98. Palantir Technologies Main Business
 Table 99. Palantir Technologies Latest Developments
 Table 100. BenevolentAI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 101. BenevolentAI Artificial Intelligence Drug R&D Product Offered
 Table 102. BenevolentAI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 103. BenevolentAI Main Business
 Table 104. BenevolentAI Latest Developments
 Table 105. Atomwise Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 106. Atomwise Artificial Intelligence Drug R&D Product Offered
 Table 107. Atomwise Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 108. Atomwise Main Business
 Table 109. Atomwise Latest Developments
 Table 110. Numerate Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 111. Numerate Artificial Intelligence Drug R&D Product Offered
 Table 112. Numerate Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 113. Numerate Main Business
 Table 114. Numerate Latest Developments
 Table 115. Recursion Pharmaceuticals Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 116. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
 Table 117. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 118. Recursion Pharmaceuticals Main Business
 Table 119. Recursion Pharmaceuticals Latest Developments
 Table 120. Exscientia Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 121. Exscientia Artificial Intelligence Drug R&D Product Offered
 Table 122. Exscientia Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 123. Exscientia Main Business
 Table 124. Exscientia Latest Developments
 Table 125. TwoXAR Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 126. TwoXAR Artificial Intelligence Drug R&D Product Offered
 Table 127. TwoXAR Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 128. TwoXAR Main Business
 Table 129. TwoXAR Latest Developments
 Table 130. AiCure Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 131. AiCure Artificial Intelligence Drug R&D Product Offered
 Table 132. AiCure Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 133. AiCure Main Business
 Table 134. AiCure Latest Developments


List of Figures
 Figure 1. Artificial Intelligence Drug R&D Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2024)
 Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2024
 Figure 10. Artificial Intelligence Drug R&D in Drug Discovery
 Figure 11. Global Artificial Intelligence Drug R&D Market: Drug Discovery (2020-2025) & ($ millions)
 Figure 12. Artificial Intelligence Drug R&D in Precision Medicine
 Figure 13. Global Artificial Intelligence Drug R&D Market: Precision Medicine (2020-2025) & ($ millions)
 Figure 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2024
 Figure 15. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2024
 Figure 16. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2020-2025)
 Figure 17. Americas Artificial Intelligence Drug R&D Market Size 2020-2025 ($ millions)
 Figure 18. APAC Artificial Intelligence Drug R&D Market Size 2020-2025 ($ millions)
 Figure 19. Europe Artificial Intelligence Drug R&D Market Size 2020-2025 ($ millions)
 Figure 20. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2020-2025 ($ millions)
 Figure 21. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2024
 Figure 22. United States Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 23. Canada Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 24. Mexico Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 25. Brazil Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 26. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2024
 Figure 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2020-2025)
 Figure 28. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2020-2025)
 Figure 29. China Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 30. Japan Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 31. South Korea Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 32. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 33. India Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 34. Australia Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2024
 Figure 36. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2020-2025)
 Figure 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2020-2025)
 Figure 38. Germany Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 39. France Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 40. UK Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 41. Italy Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 42. Russia Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2020-2025)
 Figure 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2020-2025)
 Figure 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2020-2025)
 Figure 46. Egypt Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 47. South Africa Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 48. Israel Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 49. Turkey Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 50. GCC Countries Artificial Intelligence Drug R&D Market Size Growth 2020-2025 ($ millions)
 Figure 51. Americas Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 52. APAC Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 53. Europe Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 54. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 55. United States Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 56. Canada Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 57. Mexico Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 58. Brazil Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 59. China Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 60. Japan Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 61. Korea Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 62. Southeast Asia Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 63. India Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 64. Australia Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 65. Germany Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 66. France Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 67. UK Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 68. Italy Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 69. Russia Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 70. Egypt Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 71. South Africa Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 72. Israel Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 73. Turkey Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)
 Figure 74. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2026-2031)
 Figure 75. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2026-2031)
 Figure 76. GCC Countries Artificial Intelligence Drug R&D Market Size 2026-2031 ($ millions)

Companies Mentioned

IBM Watson

BioXel

Insilico Medicine

Gatehouse Bio

Google DeepMind

Genpact Cora

Cyclica Inc

QuantumBlack

Nq Medical

Phenomic AI

Palantir Technologies

BenevolentAI

Atomwise

Numerate

Recursion Pharmaceuticals

Exscientia

TwoXAR

AiCure

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff